Eubiologics wins WHO prequalification for oral cholera vaccine
BioWorld MedTech - 2024-04-18T09:20:06.543Z

South Korea’s Eubiologics Co. Ltd. said it gained the World Health Organization’s (WHO) prequalification designation on April 16 for its simplified oral cholera vaccine, approved as Euvichol-S.

In related news

WHO prequalifies simplified version of oral cholera vaccine
Two facilities in South Korea are expected to begin producing the vaccine in the second quarter of the year, which is expected to help ease severe vaccine shortages.
- Related Articles
- In News
- From CIDRAP
- 2024-04-18T09:20:06.542Z
Why Cole Palmer's move from Manchester City to Chelsea was the rare win-win-win-win-win for all parties
As City and Chelsea square off in the FA Cup quarterfinals Palmer has the chance to eliminate his old team.
- Related Articles
- In News
- From CBS Sports
- 2024-04-20T11:00:18.003Z
Demand for the cholera vaccine is soaring – this company might have a solution
South Korea facility bears the international burden of mass producing oral cholera vaccines to stem an acute stockpile shortage
- Related Articles
- In News
- From The Telegraph
- 2024-04-25T16:02:08.000Z

In related news

WHO prequalifies simplified version of oral cholera vaccine

Why Cole Palmer's move from Manchester City to Chelsea was the rare win-win-win-win-win for all parties

Demand for the cholera vaccine is soaring – this company might have a solution